DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
PMJIX
Price
$13.94
Change
-$0.08 (-0.57%)
Updated
Jul 31 closing price
Net Assets
3.79B
Interact to see
Advertisement

DFSVX vs PMJIX

DFSVX vs PMJIX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. PMJIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and PMJIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. PMJIX (3.79B). DFSVX pays higher dividends than PMJIX: DFSVX (1.50) vs PMJIX (0.95). DFSVX was incepted earlier than PMJIX: DFSVX (33 years) vs PMJIX (11 years). PMJIX (0.50) is less costly to investors than DFSVX (0.31). PMJIX is a more actively managed with annual turnover of: 59.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than PMJIX: DFSVX (0) vs PMJIX (1000000). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. PMJIX (30.55). DFSVX return over 5 years is better than : 50.66 vs. PMJIX (1.71).
DFSVXPMJIXDFSVX / PMJIX
Total Expense Ratio0.310.5062%
Annual Report Gross Expense Ratio0.310.5062%
Fund Existence33 years11 years-
Gain YTD21.33619.862107%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B3.79B515%
Annual Yield % from dividends1.500.95159%
Returns for 1 year34.3930.55113%
Returns for 3 years50.3758.4786%
Returns for 5 years50.661.712,960%
Returns for 10 years107.7165.33165%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I